Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute (NCI)
Hoffmann-La Roche
Omico
Uppsala University Hospital
Swiss Cancer Institute
University Medical Center Groningen
University of Leicester
Jules Bordet Institute
Health Pharma Professional Research
Hoffmann-La Roche